Private company

Apellis Pharmaceuticals, Inc.

Last updated Oct 16, 2026.

Overview

  • IndustryPharmaceutical Preparations
  • HeadquartersDE
  • Incorporated inDE2
  • Business address100 Fifth Avenue, Waltham, Ma 024512
  • Filer categoryLarge accelerated filer2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

5.5%Operating margin3
2.2%Net margin3
28.5%Revenue growth, 20253
6.0%Return on equity3
$45.0MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Research and development29¢$295.9M
  • Selling, general and admin55¢$550.3M
  • Other costs13¢$133.6M
  • Income tax0¢$1.7M
  • Profit2¢$22.4M

Out of $1.0B in revenue.3

Where each dollar of operating cash went, fiscal 2025

  • Capital spending1¢$313.0K
  • Kept or used elsewhere99¢$45.0M

Out of $45.3M of cash from operations.3

Financial statements

Revenue4563$1.0B in 2025+300% since 2020
0$500.0M$1.0B$1.5B2020: $250.6M$250.6M20202021: $66.6M$66.6M2021−73%2022: $75.4M$75.4M2022+13%2023: $396.6M$396.6M2023+426%2024: $781.4M$781.4M2024+97%2025: $1.0B$1.0B2025+28%
Operating income74563$55.4M in 2025
-$600.0M-$400.0M-$200.0M0$200.0M2019: -$288.0M-$288.0M20192020: -$213.7M-$213.7M2020−26%2021: -$536.3M-$536.3M2021+151%2022: -$594.6M-$594.6M2022+11%2023: -$517.1M-$517.1M2023−13%2024: -$165.0M-$165.0M2024−68%2025: $55.4M$55.4M2025
Net income74563$22.4M in 2025
-$800.0M-$600.0M-$400.0M-$200.0M0$200.0M2019: -$304.7M-$304.7M20192020: -$344.9M-$344.9M2020+13%2021: -$746.4M-$746.4M2021+116%2022: -$652.2M-$652.2M2022−13%2023: -$528.6M-$528.6M2023−19%2024: -$197.9M-$197.9M2024−63%2025: $22.4M$22.4M2025
Fiscal year2019202020212022202320242025
Revenue$250.6M4$66.6M5$75.4M6$396.6M3$781.4M3$1.0B3
Research and development$221.0M7$299.9M4$345.9M5$387.2M6$354.4M3$327.6M3$295.9M3
Selling, general and admin$277.2M6$500.8M3$501.1M3$550.3M3
Operating income-$288.0M7-$213.7M4-$536.3M5-$594.6M6-$517.1M3-$165.0M3$55.4M3
Income tax$1.8M4$352.0K5$669.0K6$2.1M3$1.2M3$1.7M3
Net income-$304.7M7-$344.9M4-$746.4M5-$652.2M6-$528.6M3-$197.9M3$22.4M3
Earnings per share-$4.594-$8.845-$6.156-$4.453-$1.603$0.183
Earnings per share (diluted)-$4.594-$8.845-$6.156-$4.453-$1.603$0.203

Compare Apellis Pharmaceuticals, Inc. with another company

Recent filings

  1. May 14, 20268-K
  2. May 14, 20264
  3. May 14, 20264
  4. May 14, 20264
  5. May 14, 20264
  6. May 14, 20264
  7. May 14, 20264
  8. May 14, 20264
  9. May 14, 20264
  10. May 14, 20264
  11. May 14, 20264
  12. May 14, 20264
  13. May 14, 20264
  14. May 14, 20264
  15. May 14, 20264

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11